Scribe Therapeutics, Inc. ($SCTX)
Filing Information
| Accession Number | 0001781292-26-000007 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 28, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
231,399
Total Value
$45,000.00
P&L
+9341.1% (+$4,203,485.64)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Business Officer | Common Stock | โ | Jul 23, 2026 | Purchase | 3,000 | $15.00 | $45,000.00 | 3,000 | Indirect | By Spouse | View Details | |
Chief Business Officer | Stock Option (Right to Buy) | Derivative | Mar 13, 2026 | Grant/Award | 9,547 | $0.00 | $0.00 | 9,547 | Direct | โ | View Details | |
Chief Business Officer | Stock Option (Right to Buy) | Derivative | Jul 23, 2026 | Grant/Award | 109,426 | $0.00 | $0.00 | 109,426 | Direct | โ | View Details | |
Chief Business Officer | Performance-based Stock Option (Right to Buy) | Derivative | Jul 23, 2026 | Grant/Award | 109,426 | $0.00 | $0.00 | 109,426 | Direct | โ | View Details |